Detalhe da pesquisa
1.
Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer.
Future Oncol
; 20(8): 447-458, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882460
2.
Health-related quality of life in alcohol dependence: Similar cross-cultural impact beyond specific drinking habits.
J Ethn Subst Abuse
; 18(2): 279-295, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805530
3.
STREAM: Elucidating How Alcohol Use Disorders are Managed in UK General Practice Today.
Alcohol Alcohol
; 51(4): 428-35, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26801743
4.
Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data.
BMC Public Health
; 15: 1271, 2015 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690081
5.
Quality of life depends on the drinking pattern in alcohol-dependent patients.
Alcohol Alcohol
; 49(4): 457-65, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24863264
6.
A predictive microsimulation model to estimate the clinical relevance of reducing alcohol consumption in alcohol dependence.
Eur Addict Res
; 20(6): 269-84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25228120
7.
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations.
Cancers (Basel)
; 15(22)2023 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001589
8.
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.
Adv Ther
; 40(3): 1187-1203, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652175
9.
CosmeceutiQoL: a tool for assessing dermo-cosmetic products' impact on quality of life.
J Cosmet Laser Ther
; 14(1): 18-23, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22032633
10.
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis.
Target Oncol
; 17(2): 153-166, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226283
11.
HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome.
Oncologist
; 16(10): 1469-78, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21964002
12.
Epidemiology of dandruff, scalp pruritus and associated symptoms.
Acta Derm Venereol
; 93(1): 80-1, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22277979
13.
Epidemiology of pruritus in France.
Acta Derm Venereol
; 92(5): 541-2, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22504482
14.
Cost-Effectiveness of Nalmefene Added to Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol-Dependent Patients With High/Very High Drinking Risk Levels: A Microsimulation Model.
J Stud Alcohol Drugs
; 78(6): 867-876, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29087821
15.
A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence.
Appl Health Econ Health Policy
; 14(4): 493-505, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283839
16.
A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence.
Clin Drug Investig
; 36(11): 945-956, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470429
17.
Melasma: measure of the impact on quality of life using the French version of MELASQOL after cross-cultural adaptation.
Acta Derm Venereol
; 90(3): 331-2, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20526570
18.
Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk.
J Psychopharmacol
; 29(11): 1152-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26349557
19.
The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients.
PLoS One
; 10(6): e0129289, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26053024
20.
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model.
BMJ Open
; 4(9): e005376, 2014 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25227627